Scholarly Index
Soheil Meshinchi
Fred Hutch Cancer Center; 20,935 total citations; 551 total publications; best world rank #117
Fred Hutch Cancer Center
20,935Total citations
551Total publications
64H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Acute Myeloid Leukemia Research | Lifetime | 242 | US 122 | 99.29 |
| Acute Lymphoblastic Leukemia research | Lifetime | 349 | US 181 | 98.65 |
| Chronic Myeloid Leukemia Treatments | Lifetime | 501 | US 236 | 97.77 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | Lifetime | 507 | US 218 | 96.49 |
| Protein Degradation and Inhibitors | Lifetime | 598 | US 299 | 95.92 |
| Histone Deacetylase Inhibitors Research | Lifetime | 548 | US 262 | 95.26 |
| Hematopoietic Stem Cell Transplantation | Lifetime | 996 | US 468 | 96.47 |
| Retinoids in leukemia and cellular processes | Lifetime | 862 | US 414 | 94.02 |
| Neutropenia and Cancer Infections | Lifetime | 793 | US 340 | 94.01 |
| Acute Myeloid Leukemia Research | 2021-2025 | 117 | US 73 | 98.81 |
| Acute Lymphoblastic Leukemia research | 2021-2025 | 385 | US 200 | 94.00 |
| Protein Degradation and Inhibitors | 2021-2025 | 466 | US 211 | 91.17 |
| Histone Deacetylase Inhibitors Research | 2021-2025 | 304 | US 106 | 87.99 |
| Chronic Myeloid Leukemia Treatments | 2021-2025 | 630 | US 263 | 89.07 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | 2021-2025 | 802 | US 321 | 84.78 |